Elisabeth Rosenthal Triumphant music plays as cancer patients go camping, do some gardening, and watch fireworks in ads for Opdivo+Yervoy, a combination of immunotherapies to treat […] ...
In January, a new Idaho law will take effect requiring reform of business practices by pharmacy middlemen — in search of ...
The agency alleges CVS’s Caremark, Cigna’s Express Scripts and UnitedHealth’s Optum Rx accepted money from drugmakers in ...
A U.S. appeals court revived a lawsuit on Friday by healthcare and drug industry groups challenging the first-ever U.S. law ...
Attorney General Ashley Moody wanted the Florida Supreme Court to resolve a legal battle about whether local agencies could ...
Analysts have set 12-month price targets for Ultragenyx Pharmaceutical, revealing an average target of $89.7, a high estimate ...
The 11000 Cedar Startup Incubator, formerly the home of BioEnterprise Inc., is poised to bridge the commercialization gap by ...
PBMs have been under fire for years for alleged profiteering and anticompetitive conduct, but efforts to regulate the industry at the federal level have stalled in Congress.
The drop in interest rate is slightly bigger than anticipated and good news for the biotech industry, but little will change ...
Industry insiders hope the Fed’s decision to cut rates for the first time in years will boost biotech investment. But the long-awaited move won’t cure all that ails the sector, others cautioned.
A French biotechnology giant just opened a molecular and genomic innovation center at Philly’s Navy Yard after acquiring a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback